Cart
sales@molnova.com
Influenza HA 307-319
CAS No. 528526-85-4
Influenza HA 307-319( —— )
Catalog No. M30552 CAS No. 528526-85-4
Influenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameInfluenza HA 307-319
-
NoteResearch use only, not for human use.
-
Brief DescriptionInfluenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).
-
DescriptionInfluenza Hemagglutinin is an HLA-DRB 0101-restricted epitope from influenza hemagglutinin (307-319).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetInfluenza Virus
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number528526-85-4
-
Formula Weight1503.78
-
Molecular FormulaC69H118N18O19
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Pro}{Lys}{Tyr}{Val}{Lys}{Gln}{Asn}{Thr}{Leu}{Lys}{Leu}{Ala}{Thr}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Sriwilaijaroen N, et al. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(6):226-49.
molnova catalog
related products
-
CBS1117
CBS1117 is an inhibitor virus entry inhibitor(IC50 of 70 nM for influenza A virus), A/Puerto Rico/8/34 (H1N1).?It interferes with the hemagglutinin (HA)-mediated fusion process.CBS1117 which has a 50% inhibitory concentration of 70 nM and a selectivity index of ~4000 against A/Puerto Rico/8/34 (H1N1) infection in human lung epithelial cell line (A549).
-
Influenza NP 147-155
This peptide is a H-2Kd-restricted epitope from Influenza nucleoprotein (147-155).
-
EBOV-IN-1
EBOV-IN-1 is an adamantane dipeptide piperazine inhibitor against Ebola virus (EBOV) that inhibits EBOV infection and suppresses pseudotypic EBOV infection.
